These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 19130609)

  • 1. Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin.
    Fetz V; Bier C; Habtemichael N; Schuon R; Schweitzer A; Kunkel M; Engels K; Kovács AF; Schneider S; Mann W; Stauber RH; Knauer SK
    Int J Cancer; 2009 May; 124(9):2033-41. PubMed ID: 19130609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas.
    Engels K; Knauer SK; Loibl S; Fetz V; Harter P; Schweitzer A; Fisseler-Eckhoff A; Kommoss F; Hanker L; Nekljudova V; Hermanns I; Kleinert H; Mann W; du Bois A; Stauber RH
    Cancer Res; 2008 Jul; 68(13):5159-66. PubMed ID: 18593915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-I receptor signaling pathway induces resistance to the apoptotic activities of SCH66336 (lonafarnib) through Akt/mammalian target of rapamycin-mediated increases in survivin expression.
    Oh SH; Jin Q; Kim ES; Khuri FR; Lee HY
    Clin Cancer Res; 2008 Mar; 14(5):1581-9. PubMed ID: 18316583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. iNOS/NO signaling regulates apoptosis induced by glycochenodeoxycholate in hepatocytes.
    Wang K; Brems JJ; Gamelli RL; Holterman AX
    Cell Signal; 2011 Oct; 23(10):1677-85. PubMed ID: 21693187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells.
    Chao JI; Kuo PC; Hsu TS
    J Biol Chem; 2004 May; 279(19):20267-76. PubMed ID: 14988404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma.
    Franchi A; Massi D; Santucci M; Masini E; Rossi Degl'Innocenti D; Magnelli L; Fanti E; Naldini A; Ardinghi C; Carraro F; Gallo O
    J Pathol; 2006 Feb; 208(3):439-45. PubMed ID: 16278821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma.
    Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N
    Clin Cancer Res; 2002 Oct; 8(10):3131-6. PubMed ID: 12374680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-kappaB/survivin and phosphoinositide 3-kinase/Akt signaling pathways.
    Lin J; Guan Z; Wang C; Feng L; Zheng Y; Caicedo E; Bearth E; Peng JR; Gaffney P; Ondrey FG
    Clin Cancer Res; 2010 Jan; 16(1):77-87. PubMed ID: 20028744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy.
    Sharma H; Sen S; Lo Muzio L; Mariggiò A; Singh N
    Cancer Biol Ther; 2005 Jul; 4(7):720-7. PubMed ID: 15917659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear Survivin expression is correlated with malignant behaviors of head and neck cancer together with Aurora-B.
    Qi G; Kudo Y; Ando T; Tsunematsu T; Shimizu N; Siriwardena SB; Yoshida M; Keikhaee MR; Ogawa I; Takata T
    Oral Oncol; 2010 Apr; 46(4):263-70. PubMed ID: 20138567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoprotective signaling associated with nitric oxide upregulation in tumor cells subjected to photodynamic therapy-like oxidative stress.
    Bhowmick R; Girotti AW
    Free Radic Biol Med; 2013 Apr; 57():39-48. PubMed ID: 23261943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1-IRIS overexpression promotes cisplatin resistance in ovarian cancer cells.
    Chock KL; Allison JM; Shimizu Y; ElShamy WM
    Cancer Res; 2010 Nov; 70(21):8782-91. PubMed ID: 20940403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxaliplatin-mediated inhibition of survivin increases sensitivity of head and neck squamous cell carcinoma cell lines to paclitaxel.
    Khan Z; Khan N; Varma AK; Tiwari RP; Mouhamad S; Prasad GB; Bisen P
    Curr Cancer Drug Targets; 2010 Nov; 10(7):660-9. PubMed ID: 20578991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of nitric oxide on cyclooxygenase-2 (COX-2) overexpression in head and neck cancer cell lines.
    Park SW; Lee SG; Song SH; Heo DS; Park BJ; Lee DW; Kim KH; Sung MW
    Int J Cancer; 2003 Dec; 107(5):729-38. PubMed ID: 14566822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of RhoGDIα induces apoptosis and increases lung cancer cell chemosensitivity to paclitaxel.
    Rong F; Li W; Chen K; Li DM; Duan WM; Feng YZ; Li F; Zhou XW; Fan SJ; Liu Y; Tao M
    Neoplasma; 2012; 59(5):541-50. PubMed ID: 22668020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
    Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
    FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SERPINB2 down-regulation contributes to chemoresistance in head and neck cancer.
    Huang Z; Li H; Huang Q; Chen D; Han J; Wang L; Pan C; Chen W; House MG; Nephew KP; Guo Z
    Mol Carcinog; 2014 Oct; 53(10):777-86. PubMed ID: 23661500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide regulates AKT phosphorylation and nuclear translocation in cultured retinal cells.
    Mejía-García TA; Portugal CC; Encarnação TG; Prado MA; Paes-de-Carvalho R
    Cell Signal; 2013 Dec; 25(12):2424-39. PubMed ID: 23958999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
    Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
    Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin.
    Wang S; Huang X; Lee CK; Liu B
    Oncogene; 2010 Jul; 29(29):4225-36. PubMed ID: 20498641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.